Primary |
Bipolar Disorder |
32.0% |
Product Used For Unknown Indication |
24.3% |
Drug Use For Unknown Indication |
14.4% |
Schizophrenia |
9.7% |
Bipolar I Disorder |
6.6% |
Schizoaffective Disorder |
2.6% |
Psychotic Disorder |
2.6% |
Depression |
1.9% |
Anxiety |
1.1% |
Mania |
0.9% |
Affective Disorder |
0.8% |
Major Depression |
0.6% |
Bipolar Ii Disorder |
0.4% |
Insomnia |
0.4% |
Schizoaffective Disorder Bipolar Type |
0.4% |
Mental Disorder |
0.3% |
Asthma |
0.3% |
Post-traumatic Stress Disorder |
0.2% |
Schizophrenia, Paranoid Type |
0.2% |
Sleep Disorder |
0.2% |
|
Weight Increased |
11.3% |
Underdose |
10.3% |
Dysgeusia |
8.9% |
Hypoaesthesia Oral |
7.2% |
Somnolence |
7.0% |
Inappropriate Schedule Of Drug Administration |
5.7% |
Akathisia |
5.5% |
Vomiting |
5.3% |
Sedation |
4.7% |
Swollen Tongue |
4.7% |
Nausea |
3.7% |
Rash |
3.6% |
Tremor |
3.3% |
Oedema Peripheral |
3.3% |
Suicidal Ideation |
2.9% |
Incorrect Route Of Drug Administration |
2.8% |
Restless Legs Syndrome |
2.7% |
Dizziness |
2.4% |
Dystonia |
2.3% |
Extrapyramidal Disorder |
2.3% |
|
Secondary |
Bipolar Disorder |
27.7% |
Product Used For Unknown Indication |
14.4% |
Schizophrenia |
10.4% |
Bipolar I Disorder |
9.0% |
Psychotic Disorder |
8.2% |
Depression |
5.6% |
Anxiety |
4.5% |
Affective Disorder |
4.0% |
Schizoaffective Disorder |
2.9% |
Schizoaffective Disorder Bipolar Type |
1.6% |
Mood Swings |
1.5% |
Insomnia |
1.3% |
Paranoia |
1.3% |
Sleep Disorder |
1.3% |
Major Depression |
1.2% |
Post-traumatic Stress Disorder |
1.2% |
Mania |
1.1% |
Mood Altered |
1.1% |
Bipolar Ii Disorder |
0.9% |
Akathisia |
0.8% |
|
Underdose |
20.0% |
Weight Increased |
9.4% |
Inappropriate Schedule Of Drug Administration |
7.2% |
Somnolence |
6.4% |
Dysgeusia |
6.0% |
Sedation |
5.7% |
Off Label Use |
4.9% |
Restlessness |
4.5% |
Akathisia |
4.2% |
Vomiting |
4.2% |
Speech Disorder |
3.4% |
Hypoaesthesia Oral |
3.0% |
Nervousness |
3.0% |
Tremor |
3.0% |
Wrong Technique In Drug Usage Process |
3.0% |
Swollen Tongue |
2.6% |
Urinary Tract Infection |
2.6% |
Rash |
2.3% |
Suicidal Ideation |
2.3% |
Therapeutic Product Ineffective |
2.3% |
|
Concomitant |
Product Used For Unknown Indication |
14.4% |
Bipolar Disorder |
13.9% |
Depression |
11.3% |
Schizophrenia |
8.7% |
Hepatitis C |
5.2% |
Psychotic Disorder |
5.0% |
Schizoaffective Disorder |
4.7% |
Bipolar I Disorder |
3.9% |
Pain |
3.9% |
Sleep Disorder |
3.9% |
Post-traumatic Stress Disorder |
3.7% |
Anxiety |
3.4% |
Diabetes Mellitus |
3.4% |
Insomnia |
3.4% |
Hypertension |
2.4% |
Gastrooesophageal Reflux Disease |
2.1% |
Back Pain |
1.8% |
Multiple Sclerosis |
1.8% |
Arthralgia |
1.6% |
Asthma |
1.3% |
|
Incorrect Dose Administered |
8.9% |
Tremor |
8.9% |
Depression |
7.1% |
Psychotic Disorder |
7.1% |
Death |
5.4% |
Feeling Abnormal |
5.4% |
Leukopenia |
5.4% |
Pain |
5.4% |
Visual Impairment |
5.4% |
Weight Increased |
5.4% |
Cardiac Arrest |
3.6% |
Colour Blindness |
3.6% |
Drug Dose Omission |
3.6% |
Drug Ineffective |
3.6% |
Granulocytopenia |
3.6% |
Hypotension |
3.6% |
Ileus |
3.6% |
Injection Site Pain |
3.6% |
Myocarditis |
3.6% |
Schizophrenia |
3.6% |
|
Interacting |
Bipolar Disorder |
33.3% |
Convulsion |
33.3% |
Pneumonia |
33.3% |
|
Drug Interaction |
50.0% |
Pneumonia |
50.0% |
|